Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.8B | 3.6B | 3.8B | 3.9B |
| Cost of revenue | 2.8B | 2.9B | 2.8B | 2.9B |
| Gross profit | 1.0B | 664M | 1.0B | 1.0B |
| Operating expense | ||||
| Research & development | 106M | 133M | 106M | 109M |
| Selling general and admin | 580M | 649M | 596M | 826M |
| Other operating expenses | 71M | -77M | 90M | 79M |
| Operating income | 297M | -17M | 319M | 88M |
| Non operating interest income | ||||
| Income | 24M | 35M | 8M | 14M |
| Expense | 51M | 54M | 53M | 56M |
| Other income expense | — | — | — | — |
| Pretax income | 270M | -121M | 274M | 62M |
| Tax provision | 34M | 28M | 47M | 61M |
| Net income | 236M | -148M | 227M | 1M |
| Basic EPS | 0.5 | — | 0.5 | 0.0 |
| Diluted EPS | 0.5 | — | 0.5 | 0.0 |
| Basic average shares | 466M | — | 464.6M | 500M |
| Diluted average shares | 466M | — | 464.6M | 500M |
| EBITDA | 561M | 301M | 561M | 368M |
| Net income from continuing op. | 299M | -90M | 321M | 93M |
| Minority interests | -3M | -4M | -4M | -6M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |